Additional requirements for complex interventions

BMJ (Online)

Volumn 345, Issue 7885, 2012, Pages

  Spreckelsen, Thees F ^a   Grant, Sean P ^a   Montgomery, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CONFIDENTIALITY; CONFLICT OF INTEREST; DRUG INDUSTRY; HUMAN; INFORMATION PROCESSING; INTENTION TO TREAT ANALYSIS; LETTER; MEDICAL LITERATURE; METHODOLOGY; ONLINE SYSTEM; PATIENT CARE; PATIENT INFORMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; SYSTEMATIC ERROR;

ACCESS TO INFORMATION; CLINICAL TRIALS AS TOPIC; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84870533801     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e8003     Document Type: Letter

References (4)

1. Godlee F. Clinical trial data for all drugs in current use. BMJ 2012;345:e7304. (29 October.)
2. American Economic Association. The American economic review: data availability policy. www.aeaweb.org/aer/data.php.
3. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
4. Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, et al. Taking healthcare interventions from trial to practice. BMJ 2010;341:c3852.